scholarly journals Correlation of von Willebrand factor gene polymorphism and coronary heart disease

2012 ◽  
Vol 6 (5) ◽  
pp. 1107-1110 ◽  
Author(s):  
AI-GUO XU ◽  
RONG-MEI XU ◽  
CHANG-QING LU ◽  
MENG-YING YAO ◽  
WEI ZHAO ◽  
...  
Author(s):  
Margaret May ◽  
Debbie A. Lawlor ◽  
Rita Patel ◽  
Ann Rumley ◽  
Gordon Lowe ◽  
...  

Background Associations of three markers of thrombotic tendency, von Willebrand factor, tissue plasminogen activator antigen and fibrin D-dimer, with coronary heart disease have been reported in meta-analyses. It is not known, however, whether findings are generalizable to older women. Design Prospective cohort of 3582 women aged 60-79 years randomly selected from 23 towns without evidence of cardiovascular disease at entry into the British Women's Heart and Health Study. Methods Women were followed for 4.7 years for incident coronary heart disease. Cox proportional hazard models were used to compare the hazard ratio of coronary heart disease per doubling for each thrombotic factor. Results In models adjusting for age and town only there was no association between von Willebrand factor or D-dimer and incidence of coronary heart disease, but there was a positive association of tissue plasminogen activator: coronary heart disease hazard ratio per doubling was 1.37 (95% confidence interval: 1.08-1.75). Adjustment for potential confounders (socio-economic position, smoking, lung function, physical activity, alcohol consumption, body mass index, waist-to-hip ratio) attenuated association to 1.20 (0.92-1.58). Further adjustment for risk factors that may be part of the same pathophysiological process linking tissue plasminogen activator to coronary heart disease (high density lipoprotein cholesterol, triglycerides, blood pressure, fasting glucose, insulin, C-reactive protein, fibrinogen) attenuated the hazard ratio to 1.05 (0.79-1.40). Conclusion In older women, tissue plasminogen activator was associated with incident coronary heart disease, but does not appear to be an independent risk factor for coronary heart disease as the association was attenuated by adjustment for confounding and other metabolic and vascular risk factors. Eur J Cardiovasc Prev Rehabil 14:638-645 © 2007 The European Society of Cardiology


2004 ◽  
Vol 124 (3) ◽  
pp. 343-347 ◽  
Author(s):  
Irene M. Van Der Meer ◽  
Geert-Jan Brouwers ◽  
Saskia Bulk ◽  
Frank W. G. Leebeek ◽  
Deirdre A. M. Van Der Kuip ◽  
...  

1997 ◽  
Vol 77 (01) ◽  
pp. 087-093 ◽  
Author(s):  
James S Pankow ◽  
Aaron R Folsom ◽  
Michael A Province ◽  
D C Rao ◽  
John Eckfeldt ◽  
...  

SummaryIndividuals with a family history of coronary heart disease (CHD) may be predisposed to atherothrombosis. To investigate this hypothesis, a family CHD risk score was computed for approximately 13,000 men and women aged 45 to 64; hemostatic variables (fibrinogen, factor VIIc, factor VIIIc, von Willebrand factor, antithrombin III, protein C) were also measured in plasma. After adjustment for age and ethnicity, there was a statistically significant, positive association between the family risk score and four of the six hemostatic variables (fibrinogen, factor VIIc, factor VIIIc, von Willebrand factor) in women and all six hemostatic variables in men. In general, these associations were weak and substantially attenuated after adjustment for constitutional, lifestyle, and biochemical covariates. These results indicate that mean levels of selected hemostatic variables, like traditional CHD risk factors, are higher in individuals with a family history of heart disease.


2012 ◽  
Vol 10 (7) ◽  
pp. 1262-1269 ◽  
Author(s):  
J. E. van LOON ◽  
M. KAVOUSI ◽  
F. W. G. LEEBEEK ◽  
J. F. FELIX ◽  
A. HOFMAN ◽  
...  

2021 ◽  
Vol 9 (A) ◽  
pp. 1047-1051
Author(s):  
Dewi Indah Sari Siregar ◽  
Muhammad Fidel Ganis Siregar ◽  
Gontar Alamsyah Siregar ◽  
Syah Mirsya Warli

BACKGROUND: von Willebrand Factor (vWF) is a large glycoprotein mediating hemostasis and thrombosis. The roles of vWF are platelets adhesion to sites of vascular damage and stabilization of coagulation factor VIII. AIM: This study aimed to analyze the polymorphism of the vWF gene on preeclampsia (PE) in pregnancy in Medan, Indonesia. MATERIALS AND METHODS: DNA was amplified using the polymerase chain reaction and was electrophoresed in agarose 2%. Electrophoresis results were detected using Gel Doc 1000 (Biorad, USA). The sequencing method was used to identify polymorphism from vWF gene. RESULTS: From 50 samples of PE patients, the g.93308C>T vWF gene polymorphism was found with the percentage of TT, CT, and CC genotypes as 50%, 42%, and 8%, respectively. CONCLUSION: The c.93308C>T vWF gene polymorphism was found in the genotype percentage of homozygous TT, and heterozygote CT was greater than wild-type CC.


Sign in / Sign up

Export Citation Format

Share Document